Bathe a prostate tumor in metallic particles that preferentially move through permeable capillaries and into the tumor bed. Shine an infrared light on the particles. The metal, but not the tissue, absorbs infrared energy; as it heats, it destroys tumor cells. Tissue not in contact with the metal particles, ie, healthy tissue, is unaffected.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.